Search alternatives:
mean decrease » a decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
mean decrease » a decrease (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
stem decrease » step decrease (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
2 fold » _ fold (Expand Search), 5 fold (Expand Search)
-
1
The rate of lariat formation is decreased two-fold by isoginkgetin treatment.
Published 2014“…The height of each bar indicates the fold change, from vehicle- to isoginkgetin-treated cells, in the mean fraction of reads aligning to each genic feature (<i>p</i><0.02 from two-tailed <i>t</i>-tests for all ratios). …”
-
2
-
3
-
4
<i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays.
Published 2021“…Significant differences in the chimerism of SLAM cells compared to whole BM were found in KO-F mice (55.2-fold increase in CD45.2<sup>+</sup> KO-F SLAM cells as compared to CD45.2<sup>+</sup> cells in the whole BM, p = 0.0163) and KO-M mice (11.31-fold increase in CD45.2<sup>+</sup> KO-M SLAM cells as compared to CD45.2<sup>+</sup> cells in the whole BM, p = 0.0010). …”
-
5
Resveratrol decreases PKM2 expression.
Published 2013“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”
-
6
-
7
-
8
-
9
-
10
-
11
GSK343 decreased tumor stemness.
Published 2021“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
-
12
Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1.
Published 2021“…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i><sup><i>FC/FC; Vil-Cre-ERT2/+</i></sup> intestinal sections. …”
-
13
Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups.
Published 2023Subjects: -
14
-
15
hESCs-Exo decreased cancer cell proliferation and increased cancer cell death.
Published 2017Subjects: -
16
-
17
-
18
-
19
-
20